Literature DB >> 21740226

Regulation of antigenic variation in Giardia lamblia.

César G Prucca1, Fernando D Rivero, Hugo D Luján.   

Abstract

Antigenic variation, a clonal phenotypic variation developed by microorganisms, involves the permanent switching of homologous, antigenically different cell surface molecules. In pathogenic microorganisms, antigenic variation is often described as a mechanism to evade the host immune system and therefore is responsible for the generation of chronic and/or recurrent infections. However, antigenic variation has also been involved in expanding host diversity and differential courses of the diseases. The intestinal protozoan parasite Giardia lamblia undergoes antigenic variation through the continuous exchange of approximately 200 variant-specific surface proteins. Here we review the principal issues regarding the significance of antigenic variation during Giardia infections, the particular features of the variant-specific surface proteins, and the current knowledge on the mechanisms that regulate this process, as well as the relevance of disrupting antigenic variation as a novel approach to design effective antiparasitic vaccines.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21740226     DOI: 10.1146/annurev-micro-090110-102940

Source DB:  PubMed          Journal:  Annu Rev Microbiol        ISSN: 0066-4227            Impact factor:   15.500


  17 in total

Review 1.  Transmission and epidemiology of zoonotic protozoal diseases of companion animals.

Authors:  Kevin J Esch; Christine A Petersen
Journal:  Clin Microbiol Rev       Date:  2013-01       Impact factor: 26.132

2.  Treatment of giardiasis: current status and future directions.

Authors:  Richard R Watkins; Lars Eckmann
Journal:  Curr Infect Dis Rep       Date:  2014-02       Impact factor: 3.725

3.  Giardia: both a harmless commensal and a devastating pathogen.

Authors:  Herbert L DuPont
Journal:  J Clin Invest       Date:  2013-06       Impact factor: 14.808

Review 4.  Changing of the guard: How the Lyme disease spirochete subverts the host immune response.

Authors:  George Chaconas; Mildred Castellanos; Theodore B Verhey
Journal:  J Biol Chem       Date:  2019-11-21       Impact factor: 5.157

5.  Giardial triosephosphate isomerase as possible target of the cytotoxic effect of omeprazole in Giardia lamblia.

Authors:  Horacio Reyes-Vivas; Ignacio de la Mora-de la Mora; Adriana Castillo-Villanueva; Lilian Yépez-Mulia; Gloria Hernández-Alcántara; Rosalia Figueroa-Salazar; Itzhel García-Torres; Saúl Gómez-Manzo; Sara T Méndez; América Vanoye-Carlo; Jaime Marcial-Quino; Angélica Torres-Arroyo; Jesús Oria-Hernández; Pedro Gutiérrez-Castrellón; Sergio Enríquez-Flores; Gabriel López-Velázquez
Journal:  Antimicrob Agents Chemother       Date:  2014-09-15       Impact factor: 5.191

Review 6.  A systematic review and meta-analysis of the association between Giardia lamblia and endemic pediatric diarrhea in developing countries.

Authors:  Khitam Muhsen; Myron M Levine
Journal:  Clin Infect Dis       Date:  2012-12       Impact factor: 9.079

7.  Coordinated Changes in Gene Expression Throughout Encystation of Giardia intestinalis.

Authors:  Elin Einarsson; Karin Troell; Marc P Hoeppner; Manfred Grabherr; Ulf Ribacke; Staffan G Svärd
Journal:  PLoS Negl Trop Dis       Date:  2016-03-25

8.  Ubiquitination dynamics in the early-branching eukaryote Giardia intestinalis.

Authors:  Carlos A Niño; Jenny Chaparro; Paolo Soffientini; Simona Polo; Moises Wasserman
Journal:  Microbiologyopen       Date:  2013-04-23       Impact factor: 3.139

9.  Vaccination with Bivalent DNA Vaccine of α1-Giardin and CWP2 Delivered by Attenuated Salmonella typhimurium Reduces Trophozoites and Cysts in the Feces of Mice Infected with Giardia lamblia.

Authors:  Xian-Min Feng; Wen-Yu Zheng; Hong-Mei Zhang; Wen-Yan Shi; Yao Li; Bai-Ji Cui; Hui-Yan Wang
Journal:  PLoS One       Date:  2016-06-22       Impact factor: 3.240

Review 10.  Evasion of the Immune Response by Trypanosoma cruzi during Acute Infection.

Authors:  Mariana S Cardoso; João Luís Reis-Cunha; Daniella C Bartholomeu
Journal:  Front Immunol       Date:  2016-01-18       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.